NCT03753282

Brief Summary

  1. 1.The course of AVN between Initial diagnosis and total hip replacement (THA) is analysed. The impact of early interventions versus conservative therapy in AVN before THA will be evaluated.
  2. 2.The short and long term outcomes of AVN patients undergoing THA with respect to complications, reoperations and quality of life are investigated. Potential risk factors for adverse outcomes will be investigated.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 26, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

January 30, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2019

Completed
Last Updated

March 29, 2019

Status Verified

March 1, 2019

Enrollment Period

1 month

First QC Date

November 23, 2018

Last Update Submit

March 27, 2019

Conditions

Keywords

Total hip arthroplastyTotal hip replacement

Outcome Measures

Primary Outcomes (2)

  • arthroplasty-free interval (time until THA)

    time from first diagnosis of AVN to joint replacement = time to event data (in the years between 1999-2006)

    single time point assessment at baseline

  • rate of reoperations after THA

    reoperation after THA = time to event data (in the years between 2000-2007)

    single time point assessment at baseline

Secondary Outcomes (2)

  • Hip disability and Osteoarthritis Outcome Score (HOOS)

    single time point assessment at baseline

  • Euroquol 5 Dimensions (EQ-5D-5L)

    single time point assessment at baseline

Study Arms (2)

Population 1

Patients with a first AVN-related contact (initial or confirmed diagnosis) at the Universitätsspital Basel (USB) or Kantonsspital Basel-Liestal (KSBL) in the years between 1999-2006 (being assessed by questionnaires for patient reported outcome and questionnaire for course of the disease)

Other: questionnaires for patient reported outcomeOther: questionnaire for course of the disease

Population 2

Patients with a THA because of AVN in the years 2000-2007 (being assessed by questionnaires for patient reported outcome and questionnaire for course of the disease)

Other: questionnaires for patient reported outcomeOther: questionnaire for course of the disease

Interventions

questionnaires with respect to outcomes: * Reoperations * Short term complications * Long term complications * EQ-5D (current) * HOOS (current) * disease related change of occupation * use of walking aids * comorbidities * medication

Population 1Population 2

questionnaires to assess course of the disease: * from initial diagnosis of AVN to joint replacement as total hip arthroplasty (THA) * therapeutic interventions

Population 1Population 2

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Population 1: Patients with a first AVN-related contact (initial or confirmed diagnosis) at the USB or KSBL Liestal in the years between 1999-2006. Population 2: Patients with a THA because of AVN at the USB or KSBL Liestal in the years 2000-2007.

You may qualify if:

  • MRI of the hip available from diagnosis at the USB or KSBL Liestal
  • Informed Consent

You may not qualify if:

  • Insufficient knowledge of project languages (English, German, French)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Femur Head Necrosis

Interventions

Surveys and QuestionnairesPatient Reported Outcome Measures

Condition Hierarchy (Ancestors)

OsteonecrosisBone DiseasesMusculoskeletal DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthHealth Care SurveysHealth Services ResearchHealth PlanningHealth Care Economics and OrganizationsPatient Outcome AssessmentOutcome Assessment, Health CareOutcome and Process Assessment, Health CareHealth Services Administration

Study Officials

  • Franziska Saxer, Dr. med

    Dep. of Orthopedic and Trauma Surgery; University Hospital Basel

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2018

First Posted

November 26, 2018

Study Start

January 30, 2019

Primary Completion

March 5, 2019

Study Completion

March 5, 2019

Last Updated

March 29, 2019

Record last verified: 2019-03